医薬品試験・分析サービスの世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）

世界の医薬品試験・分析サービスの市場規模は、2023年に79億8,000万米ドルに達し、2024～2032年にかけてCAGR 7.19%で成長し、2032年には149億1,000万米ドルに達すると予測されています。

医薬品試験・分析サービスには、医薬品原料・製品の安全性、品質、有効性を評価するために使用されるさまざまなラボ技術や手法が含まれます。これらのサービスには、医薬品原料、中間体、最終製品を試験し、規制基準、薬局方要件、品質仕様への適合を確認することが含まれます。医薬品試験には、化学分析、微生物試験、安定性試験、溶出試験、バイオアベイラビリティ試験などが含まれます。分析サービスは、医薬品製剤の同一性、純度、力価、安定性に関する重要な情報を提供し、医薬品開発、製造、薬事承認プロセスをサポートします。

市場力学

規制当局が医薬品の安全性、有効性、品質を重視する傾向が強まっていることから、包括的な試験・分析サービスの需要が高まっています。医薬品試験・分析サービスは、規制基準の遵守、不純物の特定、医薬品の力価、安定性、純度の検証において極めて重要です。さらに、生物製剤、バイオシミラー、特殊医薬品を含む医薬品製剤の複雑化により、規制要件を遵守し、製品の品質を確保するための高度な分析技術と専門的な試験サービスの必要性が高まっています。さらに、研究開発投資の急増、慢性疾患の急増、個別化医療に対する需要の高まりなどの要因によって拡大する製薬・バイオテクノロジー産業は、医薬品開発業務受託機関（CRO）や医薬品製造業務受託機関（CMO）からの試験・分析サービスのアウトソーシング需要を促進しています。さらに、医薬品試験・分析サービスにおける質量分析、クロマトグラフィー、分光学、分子診断学などの先端技術の採用が加速しており、分析手法の精度、感度、スループットが向上していることが、市場成長の原動力となっています。

さらに、製薬産業における非中核業務のアウトソーシング、コスト抑制戦略、業務効率化の動向の高まりが、専門プロバイダーへの試験・分析サービスのアウトソーシング需要を促進しています。さらに、製品の特性評価、プロセスバリデーション、品質管理に対する規制要件の拡大が、コンプライアンス、メソッド開発、バリデーションの専門知識を提供する専門的な試験サービスへの需要を促進しています。さらに、医薬品製造施設におけるバイオセーフティ、バイオセキュリティ、汚染管理への関心の高まりが、環境モニタリング、微生物試験、無菌試験サービスの需要を促進し、市場成長に寄与しています。しかし、競合と規制要件の増加は、今後数年間の医薬品試験・分析サービス市場の開拓に課題をもたらす可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、産業の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは医薬品試験・分析サービスの世界市場における各セグメントを包括的に評価することもできます。医薬品試験・分析サービス産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

医薬品試験・分析サービス市場レポートでは、国・地域レベルのセグメントに関する詳細なデータを提供することで、戦略担当者が各製品・サービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

サービスタイプ別

• バイオ分析試験
• メソッド開発とバリデーション
• 原料試験
• 安定性試験
• 微生物試験
• その他

エンドユーザー別

• 医療機器企業
• 製薬・バイオ医薬品企業
• その他

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける医薬品試験・分析サービス市場の現在と将来の需要を強調する地域展望を取り上げます。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 医薬品試験・分析サービス - 産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 産業動向
• ポーターのファイブフォース分析
• 市場魅力度分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 医薬品試験・分析サービスの世界市場分析：サービスタイプ別

• 概要：サービスタイプ別
• 実績データと予測データ
• 分析：サービスタイプ別
• バイオ分析試験
• メソッド開発とバリデーション
• 原料試験
• 安定性試験
• 微生物試験
• その他

第6章 医薬品試験・分析サービスの世界市場分析：エンドユーザー別

• 概要：エンドユーザー別
• 実績データと予測データ
• 分析：エンドユーザー別
• 医療機器企業
• 製薬・バイオ医薬品企業
• その他

第7章 医薬品試験・分析サービスの世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他の欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他のアジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他のラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ

第8章 医薬品試験・分析サービス企業の競合情勢

• 医薬品試験・分析サービス市場の競合
• 提携・協力・合意
• 合併・買収
• 新製品の上市
• その他の開発

第9章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Eurofins Scientific
• Laboratory Corporation of America Holdings
• Charles River Laboratories International Inc.
• SGS S.A.
• Intertek Group plc
• RD laboratories Inc.
• Wuxi AppTec Co. Ltd.
• Dynalabs LLC（Infinity Laboratories）
• ARL Bio Pharma

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Service Type (USD MN)
• Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Market Sales by Geography (USD MN)
• Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Market Sales by Geography (USD MN)
• Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Market Sales by Geography (USD MN)
• Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Market Sales by Geography (USD MN)
• Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by End-user (USD MN)
• Medical Device Companies Market Sales by Geography (USD MN)
• Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Pharmaceutical Testing And Analytical Services Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Pharmaceutical Testing And Analytical Services Report
• Market Research Process
• Market Research Methodology
• Global Pharmaceutical Testing And Analytical Services Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Service Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Service Type (USD MN)
• Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Market Sales by Geography (USD MN)
• Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Market Sales by Geography (USD MN)
• Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Market Sales by Geography (USD MN)
• Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Market Sales by Geography (USD MN)
• Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Medical Device Companies Market Sales by Geography (USD MN)
• Pharmaceutical & Biopharmaceutical Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Pharmaceutical Testing and Analytical Services Market is presumed to reach the market size of nearly USD 14.91 Billion by 2032 from USD 7.98 Billion in 2023 with a CAGR of 7.19% under the study period 2024 - 2032.

Pharmaceutical testing and analytical services encompass a range of laboratory techniques and methods used to assess the safety, quality, and effectiveness of pharmaceutical ingredients & products. These services involve testing pharmaceutical raw materials, intermediates, and finished products to ensure compliance with regulatory standards, pharmacopeial requirements, and quality specifications. Pharmaceutical testing may include chemical analysis, microbiological testing, stability testing, dissolution testing, and bioavailability studies. Analytical services provide critical information on pharmaceutical formulations' identity, purity, potency, and stability, supporting drug development, manufacturing, and regulatory approval processes.

MARKET DYNAMICS

The increasing emphasis by regulatory authorities on drug safety, efficacy, and quality drives the demand for comprehensive testing and analytical services. Pharmaceutical testing and analytical services are crucial in ensuring compliance with regulatory standards, identifying impurities, and validating pharmaceutical products' potency, stability, and purity. Moreover, the growing complexity of drug formulations, including biologics, biosimilars, and specialty drugs, drives the need for advanced analytical techniques and specialized testing services to adhere to regulatory requirements and ensure product quality. Additionally, the expanding pharmaceutical and biotechnology industry, driven by factors such as surging R&D investments, spurring prevalence of chronic diseases, and growing demand for personalized medicine, is fueling the demand for outsourced testing and analytical services from contract research organizations (CROs) and contract manufacturing organizations (CMOs). Furthermore, the spurring adoption of advanced technologies such as mass spectrometry, chromatography, spectroscopy, and molecular diagnostics in pharmaceutical testing and analytical services is enhancing analytical methods' accuracy, sensitivity, and throughput, thereby driving market growth.

Moreover, the rising trend of outsourcing non-core activities, cost containment strategies, and operational efficiencies in the pharmaceutical industry is driving the demand for outsourcing testing and analytical services to specialized providers. Additionally, the expanding regulatory requirements for product characterization, process validation, and quality control drive the demand for specialized testing services that offer expertise in compliance, method development, and validation. Furthermore, the growing focus on biosafety, biosecurity, and contamination control in pharmaceutical manufacturing facilities is driving the demand for environmental monitoring, microbial testing, and sterility testing services, contributing to market growth. However, increasing competition and regulatory requirements may challenge the development of the pharmaceutical testing and analytical services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical testing and analytical services. The growth and trends of pharmaceutical testing and analytical services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pharmaceutical testing and analytical services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

• Bioanalytical Testing (Cell-Based Assays, Virology Testing, And Others)
• Method Development & Validation (Extractables & Leachables Method Development And Validation, Stability-Indicating Method Validation, Process Impurity Method Development & Validation, And Others)
• Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, And Others)
• Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, And Others)
• Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, And Others)
• Others

By End-User

• Medical Device Companies
• Pharmaceutical & Biopharmaceutical Companies
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Testing and Analytical Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Testing and Analytical Services market include Eurofins Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., Dynalabs LLC (Infinity Laboratories), ARL Bio Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Service Type
  • 3.7.2 Market Attractiveness Analysis By End-user
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY SERVICE TYPE

• 5.1 Overview by Service Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Service Type
• 5.4 Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Historic and Forecast Sales by Regions
• 5.5 Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Historic and Forecast Sales by Regions
• 5.6 Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Historic and Forecast Sales by Regions
• 5.7 Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Historic and Forecast Sales by Regions
• 5.8 Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Historic and Forecast Sales by Regions
• 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY END-USER

• 6.1 Overview by End-user
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End-user
• 6.4 Medical Device Companies Historic and Forecast Sales by Regions
• 6.5 Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES COMPANIES

• 8.1. Pharmaceutical Testing And Analytical Services Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Eurofins Scientific
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Laboratory Corporation of America Holdings
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Charles River Laboratories International Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. SGS S.A.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Intertek Group plc
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. RD laboratories Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Wuxi AppTec Co. Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Dynalabs LLC (Infinity Laboratories)
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. ARL Bio Pharma
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies